Disease burden metrics and the innovations of leading pharmaceutical companies: a global and regional comparative study

BACKGROUND: The recent innovation activities of global top-tier pharmaceutical companies in accordance with global and regional health concerns were investigated in order to identify their innovations contributing to population health. METHODS: “Innovation activity” was defined as the number of drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Ye Lim, Hwang, JeeNa, Yoo, Hyoung Sun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481343/
https://www.ncbi.nlm.nih.gov/pubmed/32912258
http://dx.doi.org/10.1186/s12992-020-00610-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481343/
https://www.ncbi.nlm.nih.gov/pubmed/32912258
http://dx.doi.org/10.1186/s12992-020-00610-2

Ejemplares similares